Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Higton, DM
   A rapid, automated approach to optimisation of multiple reaction monitoring conditions for quantitative bioanalytical mass spectrometry
   RAPID COMMUNICATIONS IN MASS SPECTROMETRY
   
   D.M. Higton, "A rapid, automated approach to optimisation of multiple reaction monitoring conditions for quantitative bioanalytical mass spectrometry", RAP C MASS, 15(20), 2001, pp. 1922-1930
2. Totsuka, K; Shimizu, K; Mori, N; Sugihara, T; Sakai, A; Yamaji, S; Michisuji, Y; Shinohara, Y; Kubo, A; Tokuoka, H
   Effects of food intake and age on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic. Comparison with cefpodoxime proxetil
   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
   
   K. Totsuka et al., "Effects of food intake and age on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic. Comparison with cefpodoxime proxetil", INT J ANT A, 18(5), 2001, pp. 463-469
3. Rajanikanth, M; Gupta, RC
   LC fluorescence method for multiple synthetic compounds to rapidly create in vivo pharmacokinetic database utilizing 'N-in-One' dosing
   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
   
   M. Rajanikanth e R.C. Gupta, "LC fluorescence method for multiple synthetic compounds to rapidly create in vivo pharmacokinetic database utilizing 'N-in-One' dosing", J PHARM B, 26(4), 2001, pp. 519-530
4. White, RE; Manitpisitkul, P
   Pharmacokinetic theory of cassette dosing in drug discovery screening
   DRUG METABOLISM AND DISPOSITION
   
   R.E. White e P. Manitpisitkul, "Pharmacokinetic theory of cassette dosing in drug discovery screening", DRUG META D, 29(7), 2001, pp. 957-966
5. Chen, CL; Venkatachalam, TK; Waurzyniak, B; Chelstrom, L; Uckun, FM
   In vivo toxicity, pharmacokinetic features and tissue distribution of N-[2-(2,5-dimethoxyphenylethyl)]-N '-[2-(5-bromopyridyl)]-thiourea (HI-236), a potent non-nucleoside inhibitor of HIV-1 reverse transcriptase
   ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
   
   C.L. Chen et al., "In vivo toxicity, pharmacokinetic features and tissue distribution of N-[2-(2,5-dimethoxyphenylethyl)]-N '-[2-(5-bromopyridyl)]-thiourea (HI-236), a potent non-nucleoside inhibitor of HIV-1 reverse transcriptase", ARZNEI-FOR, 51(7), 2001, pp. 574-581
6. Hoshen, MB; Na-Bangchang, K; Stein, WD; Ginsburg, H
   Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of 'dormancy', a partial cytostatic effect of the drug, and its implication for treatment regimens
   PARASITOLOGY
   
   M.B. Hoshen et al., "Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of 'dormancy', a partial cytostatic effect of the drug, and its implication for treatment regimens", PARASITOL, 121, 2000, pp. 237-246
7. RAOOF AA; AUGUSTIJNS PF; VERBEECK RK
   IN-VIVO ASSESSMENT OF INTESTINAL, HEPATIC, AND PULMONARY FIRST PASS METABOLISM OF PROPOFOL IN THE RAT
   Pharmaceutical research
   
   A.A. Raoof et al., "IN-VIVO ASSESSMENT OF INTESTINAL, HEPATIC, AND PULMONARY FIRST PASS METABOLISM OF PROPOFOL IN THE RAT", Pharmaceutical research, 13(6), 1996, pp. 891-895
8. CHIEN YW
   BIOPHARMACEUTICS BASIS FOR TRANSMUCOSAL DELIVERY
   STP pharma sciences
   
   Y.W. Chien, "BIOPHARMACEUTICS BASIS FOR TRANSMUCOSAL DELIVERY", STP pharma sciences, 5(4), 1995, pp. 257-275
9. BOULAY SF; GITLER MS; SOOD VK; COHEN VI; ZEEBERG BR; REBA RC
   COMPARISON OF THE IN-VIVO RAT-BRAIN REGIONAL PHARMACOKINETICS OF [H-3] QNB, (R,S)-[I-125]-4IQNB, AND (R,R)-[I-125]-4IQNB BINDING TO THE MUSCARINIC ACETYLCHOLINE-RECEPTOR IN RELATIONSHIP TO THE REGIONAL SUBTYPECOMPOSITION
   Receptor
   
   S.F. Boulay et al., "COMPARISON OF THE IN-VIVO RAT-BRAIN REGIONAL PHARMACOKINETICS OF [H-3] QNB, (R,S)-[I-125]-4IQNB, AND (R,R)-[I-125]-4IQNB BINDING TO THE MUSCARINIC ACETYLCHOLINE-RECEPTOR IN RELATIONSHIP TO THE REGIONAL SUBTYPECOMPOSITION", Receptor, 5(4), 1995, pp. 207-218
10. SZKLARCZYK A; KACZMAREK L
    ANTISENSE OLIGODEOXYRIBONUCLEOTIDES - STABILITY AND DISTRIBUTION AFTER INTRACEREBRAL INJECTION INTO RAT-BRAIN
    Journal of neuroscience methods
    
    A. Szklarczyk e L. Kaczmarek, "ANTISENSE OLIGODEOXYRIBONUCLEOTIDES - STABILITY AND DISTRIBUTION AFTER INTRACEREBRAL INJECTION INTO RAT-BRAIN", Journal of neuroscience methods, 60(1-2), 1995, pp. 181-187
11. KARA J; ZIMAKOVA NI; SEREBRYAKOVA EA; DEDKOVA V; ZOLOTARYOV AE
    PHARMACOKINETICS AND METABOLISM OF A NEW ANTITUMOR SEMISYNTHETIC ETHER PHOSPHOLIPID, C-14-LABELED PLASMANYL-(N-ACYL)ETHANOLAMINE, IN MICE BEARING SARCOMA MC11
    Journal of cancer research and clinical oncology
    
    J. Kara et al., "PHARMACOKINETICS AND METABOLISM OF A NEW ANTITUMOR SEMISYNTHETIC ETHER PHOSPHOLIPID, C-14-LABELED PLASMANYL-(N-ACYL)ETHANOLAMINE, IN MICE BEARING SARCOMA MC11", Journal of cancer research and clinical oncology, 120(11), 1994, pp. 662-667
12. PORT RE; SCHLEMMER HP; BACHERT P
    PHARMACOKINETIC ANALYSIS OF SPARSE IN-VIVO NMR-SPECTROSCOPY DATA USING RELATIVE PARAMETERS AND THE POPULATION APPROACH
    European Journal of Clinical Pharmacology
    
    R.E. Port et al., "PHARMACOKINETIC ANALYSIS OF SPARSE IN-VIVO NMR-SPECTROSCOPY DATA USING RELATIVE PARAMETERS AND THE POPULATION APPROACH", European Journal of Clinical Pharmacology, 47(2), 1994, pp. 187-193